Yale, Mayo and FDA experts aim to rethink heart failure trials with Apple WatchA group of scientists from Yale University and the Mayo Clinic are to use an Apple Watch app Share XYale, Mayo and FDA experts aim to rethink heart failure trials with Apple Watchhttps://pharmaphorum.com/news/yale-mayo-and-fda-experts-aim-to-rethink-heart-failure-trials-with-apple-watch/
Huami set to launch ECG watches outside ChinaHuami is to make its new crop of electrocardiogram smartwatches available to international markets, according to a press Share XHuami set to launch ECG watches outside Chinahttps://pharmaphorum.com/news/huami-set-to-launch-ecg-watches-outside-china/
FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRIBayer’s Gadavist has become the first imaging agent approved in the US to detect blockages in the hearts Share XFDA clears Bayer’s Gadavist as first contrast agent for cardiac MRIhttps://pharmaphorum.com/news/fda-clears-bayers-gadavist-as-first-contrast-agent-for-cardiac-mri/
Biotech Verve launches on mission to replace statins with CRISPR gene editing techCould CRISPR gene editing one day replace the need for cholesterol-lowering drugs such as statins? US biotech Verve Share XBiotech Verve launches on mission to replace statins with CRISPR gene editing techhttps://pharmaphorum.com/news/biotech-verve-launches-on-mission-to-replace-statins-with-crispr-gene-editing-tech/
Cholesterol drug from Sanofi/Regeneron gains US CV risk reduction useSanofi and Regeneron’s Praluent cholesterol drug has been approved in the US to help prevent cardiovascular events, a Share XCholesterol drug from Sanofi/Regeneron gains US CV risk reduction usehttps://pharmaphorum.com/news/cholesterol-drug-from-sanofi-regeneron-gains-us-cv-risk-reduction-use/
Bayer and J&J settle Xarelto lawsuits in USBayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits worth more than $775 Share XBayer and J&J settle Xarelto lawsuits in UShttps://pharmaphorum.com/news/bayer-and-jj-settle-xarelto-lawsuits-in-us/
Medtronic defribillators vulnerable to hacking, says FDAThe FDA and US government cyber experts have warned that hundreds of thousands of implantable defibrillators from manufacturer Share XMedtronic defribillators vulnerable to hacking, says FDAhttps://pharmaphorum.com/digital/medtronic-defribillators-vulnerable-to-hacking-says-fda/
Esperion’s cholesterol-lowering pill works when statins failA cholesterol lowering daily pill from US pharma Esperion, which can be used when statins are not working Share XEsperion’s cholesterol-lowering pill works when statins failhttps://pharmaphorum.com/news/esperions-cholesterol-lowering-pill-works-when-statins-fail/
NICE suggests lower threshold for hypertension treatmentThousands more patients could benefit from drugs and treatment for hypertension under new guidance from NICE, which has Share XNICE suggests lower threshold for hypertension treatmenthttps://pharmaphorum.com/news/nice-suggests-lower-threshold-for-hypertension-treatment-embargo/
